STOCK TITAN

[Form 4] LifeMD, Inc. 8.875% Series A Cumulative Perpetual Preferred Stock Insider Trading Activity

Filing Impact
(Low)
Filing Sentiment
(Neutral)
Form Type
4
Rhea-AI Filing Summary

On 29-Jul-2025, Christopher Zender, EVP & COO of Ollie’s Bargain Outlet (OLLI), filed a Form 4 disclosing routine equity-compensation activity. A total of 758 restricted stock units vested and automatically converted into the same number of common shares (Code “M”) at $0 exercise cost. To cover federal and state withholding taxes, 338 shares were immediately surrendered to the issuer (Code “F”) at the $137.89 closing price, an exempt transaction under Rule 16b-3. After these entries Zender directly holds 420 common shares and 2,274 unvested RSUs, which continue to vest in 25 % annual tranches through 29-Jul-2028. No open-market buying or selling occurred, and the filing does not signal a change in strategic outlook or fundamentals for OLLI.

Il 29 luglio 2025, Christopher Zender, EVP e COO di Ollie’s Bargain Outlet (OLLI), ha presentato un Modulo 4 per comunicare un'attività ordinaria di compensazione azionaria. Un totale di 758 unità di azioni vincolate sono maturate e si sono automaticamente convertite nello stesso numero di azioni ordinarie (Codice “M”) a un costo di esercizio pari a $0. Per coprire le imposte federali e statali alla fonte, 338 azioni sono state immediatamente restituite all'emittente (Codice “F”) al prezzo di chiusura di $137,89, una transazione esente ai sensi della Regola 16b-3. Dopo queste operazioni, Zender detiene direttamente 420 azioni ordinarie e 2.274 RSU non maturate, che continueranno a maturare in tranche annuali del 25% fino al 29 luglio 2028. Non si sono verificati acquisti o vendite sul mercato aperto, e la comunicazione non indica un cambiamento nella visione strategica o nei fondamentali di OLLI.

El 29 de julio de 2025, Christopher Zender, EVP y COO de Ollie’s Bargain Outlet (OLLI), presentó un Formulario 4 revelando una actividad rutinaria de compensación en acciones. Un total de 758 unidades de acciones restringidas se consolidaron y se convirtieron automáticamente en el mismo número de acciones comunes (Código “M”) con un costo de ejercicio de $0. Para cubrir los impuestos federales y estatales retenidos, se entregaron inmediatamente 338 acciones al emisor (Código “F”) al precio de cierre de $137.89, una transacción exenta bajo la Regla 16b-3. Después de estas operaciones, Zender posee directamente 420 acciones comunes y 2,274 RSU no consolidadas, que continúan consolidándose en tramos anuales del 25 % hasta el 29 de julio de 2028. No hubo compras ni ventas en el mercado abierto, y la presentación no señala un cambio en la perspectiva estratégica ni en los fundamentos de OLLI.

2025년 7월 29일, Ollie’s Bargain Outlet(OLLI)의 EVP 겸 COO인 Christopher Zender가 일상적인 주식 보상 활동을 공개하는 Form 4를 제출했습니다. 총 758개의 제한 주식 단위(RSU)가 성숙하여 동일한 수의 보통주(코드 “M”)로 자동 전환되었으며, 행사 비용은 $0였습니다. 연방 및 주 원천징수세를 충당하기 위해 338주가 즉시 발행사에 반환되었으며(코드 “F”), $137.89 종가로 거래되었는데, 이는 규칙 16b-3에 따른 면제 거래입니다. 이 거래 이후 Zender는 직접 420주 보통주2,274개의 미성숙 RSU를 보유하고 있으며, 이 RSU는 2028년 7월 29일까지 매년 25%씩 계속해서 성숙합니다. 공개 시장에서의 매매는 없었으며, 이번 제출은 OLLI의 전략적 전망이나 기본 사항에 변화를 의미하지 않습니다.

Le 29 juillet 2025, Christopher Zender, EVP et COO d’Ollie’s Bargain Outlet (OLLI), a déposé un formulaire 4 révélant une activité courante de rémunération en actions. Un total de 758 unités d’actions restreintes ont été acquises et automatiquement converties en un nombre égal d’actions ordinaires (Code « M ») avec un coût d’exercice de 0 $. Pour couvrir les retenues fiscales fédérales et étatiques, 338 actions ont été immédiatement remises à l’émetteur (Code « F ») au cours de clôture de 137,89 $, une transaction exonérée en vertu de la règle 16b-3. Après ces opérations, Zender détient directement 420 actions ordinaires et 2 274 RSU non acquises, qui continueront à s’acquérir par tranches annuelles de 25 % jusqu’au 29 juillet 2028. Aucune opération d’achat ou de vente sur le marché ouvert n’a eu lieu, et ce dépôt ne signale aucun changement dans la perspective stratégique ou les fondamentaux d’OLLI.

Am 29. Juli 2025 reichte Christopher Zender, EVP & COO von Ollie’s Bargain Outlet (OLLI), ein Formular 4 ein, das routinemäßige Aktienvergütungsaktivitäten offenlegt. Insgesamt 758 Restricted Stock Units wurden fällig und automatisch in die gleiche Anzahl von Stammaktien (Code „M“) zu keinen Ausübungskosten umgewandelt. Zur Deckung der bundesstaatlichen und staatlichen Quellensteuern wurden 338 Aktien sofort an den Emittenten zurückgegeben (Code „F“) zum Schlusskurs von 137,89 $, eine von Regel 16b-3 ausgenommene Transaktion. Nach diesen Buchungen hält Zender direkt 420 Stammaktien und 2.274 nicht fällige RSUs, die weiterhin in jährlichen Tranchen von 25 % bis zum 29. Juli 2028 fällig werden. Es gab keinen Kauf oder Verkauf am freien Markt, und die Einreichung signalisiert keine Änderung der strategischen Ausrichtung oder der Fundamentaldaten von OLLI.

Positive
  • None.
Negative
  • None.

Insights

TL;DR: Routine RSU vesting; limited investment signal, neutral impact.

The Form 4 reflects standard compensation mechanics rather than discretionary trading. Zender’s net ownership rose by 420 shares, a de-minimis amount relative to OLLI’s ~61 m share float, so dilution or insider-sentiment conclusions are unwarranted. The tax-withholding disposal is exempt and cashless, leaving the executive aligned with shareholders via 2,274 remaining RSUs that vest over three years. Given the absence of open-market sales, material value, or unusual timing, I classify the filing as neutral for investors.

Il 29 luglio 2025, Christopher Zender, EVP e COO di Ollie’s Bargain Outlet (OLLI), ha presentato un Modulo 4 per comunicare un'attività ordinaria di compensazione azionaria. Un totale di 758 unità di azioni vincolate sono maturate e si sono automaticamente convertite nello stesso numero di azioni ordinarie (Codice “M”) a un costo di esercizio pari a $0. Per coprire le imposte federali e statali alla fonte, 338 azioni sono state immediatamente restituite all'emittente (Codice “F”) al prezzo di chiusura di $137,89, una transazione esente ai sensi della Regola 16b-3. Dopo queste operazioni, Zender detiene direttamente 420 azioni ordinarie e 2.274 RSU non maturate, che continueranno a maturare in tranche annuali del 25% fino al 29 luglio 2028. Non si sono verificati acquisti o vendite sul mercato aperto, e la comunicazione non indica un cambiamento nella visione strategica o nei fondamentali di OLLI.

El 29 de julio de 2025, Christopher Zender, EVP y COO de Ollie’s Bargain Outlet (OLLI), presentó un Formulario 4 revelando una actividad rutinaria de compensación en acciones. Un total de 758 unidades de acciones restringidas se consolidaron y se convirtieron automáticamente en el mismo número de acciones comunes (Código “M”) con un costo de ejercicio de $0. Para cubrir los impuestos federales y estatales retenidos, se entregaron inmediatamente 338 acciones al emisor (Código “F”) al precio de cierre de $137.89, una transacción exenta bajo la Regla 16b-3. Después de estas operaciones, Zender posee directamente 420 acciones comunes y 2,274 RSU no consolidadas, que continúan consolidándose en tramos anuales del 25 % hasta el 29 de julio de 2028. No hubo compras ni ventas en el mercado abierto, y la presentación no señala un cambio en la perspectiva estratégica ni en los fundamentos de OLLI.

2025년 7월 29일, Ollie’s Bargain Outlet(OLLI)의 EVP 겸 COO인 Christopher Zender가 일상적인 주식 보상 활동을 공개하는 Form 4를 제출했습니다. 총 758개의 제한 주식 단위(RSU)가 성숙하여 동일한 수의 보통주(코드 “M”)로 자동 전환되었으며, 행사 비용은 $0였습니다. 연방 및 주 원천징수세를 충당하기 위해 338주가 즉시 발행사에 반환되었으며(코드 “F”), $137.89 종가로 거래되었는데, 이는 규칙 16b-3에 따른 면제 거래입니다. 이 거래 이후 Zender는 직접 420주 보통주2,274개의 미성숙 RSU를 보유하고 있으며, 이 RSU는 2028년 7월 29일까지 매년 25%씩 계속해서 성숙합니다. 공개 시장에서의 매매는 없었으며, 이번 제출은 OLLI의 전략적 전망이나 기본 사항에 변화를 의미하지 않습니다.

Le 29 juillet 2025, Christopher Zender, EVP et COO d’Ollie’s Bargain Outlet (OLLI), a déposé un formulaire 4 révélant une activité courante de rémunération en actions. Un total de 758 unités d’actions restreintes ont été acquises et automatiquement converties en un nombre égal d’actions ordinaires (Code « M ») avec un coût d’exercice de 0 $. Pour couvrir les retenues fiscales fédérales et étatiques, 338 actions ont été immédiatement remises à l’émetteur (Code « F ») au cours de clôture de 137,89 $, une transaction exonérée en vertu de la règle 16b-3. Après ces opérations, Zender détient directement 420 actions ordinaires et 2 274 RSU non acquises, qui continueront à s’acquérir par tranches annuelles de 25 % jusqu’au 29 juillet 2028. Aucune opération d’achat ou de vente sur le marché ouvert n’a eu lieu, et ce dépôt ne signale aucun changement dans la perspective stratégique ou les fondamentaux d’OLLI.

Am 29. Juli 2025 reichte Christopher Zender, EVP & COO von Ollie’s Bargain Outlet (OLLI), ein Formular 4 ein, das routinemäßige Aktienvergütungsaktivitäten offenlegt. Insgesamt 758 Restricted Stock Units wurden fällig und automatisch in die gleiche Anzahl von Stammaktien (Code „M“) zu keinen Ausübungskosten umgewandelt. Zur Deckung der bundesstaatlichen und staatlichen Quellensteuern wurden 338 Aktien sofort an den Emittenten zurückgegeben (Code „F“) zum Schlusskurs von 137,89 $, eine von Regel 16b-3 ausgenommene Transaktion. Nach diesen Buchungen hält Zender direkt 420 Stammaktien und 2.274 nicht fällige RSUs, die weiterhin in jährlichen Tranchen von 25 % bis zum 29. Juli 2028 fällig werden. Es gab keinen Kauf oder Verkauf am freien Markt, und die Einreichung signalisiert keine Änderung der strategischen Ausrichtung oder der Fundamentaldaten von OLLI.

SEC Form 4
FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response: 0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
Dray Shayna Webb

(Last) (First) (Middle)
236 FIFTH AVENUE, SUITE 400

(Street)
NEW YORK NY 10001

(City) (State) (Zip)
2. Issuer Name and Ticker or Trading Symbol
LifeMD, Inc. [ LFMD ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
Director 10% Owner
X Officer (give title below) Other (specify below)
Chief Operating Officer
3. Date of Earliest Transaction (Month/Day/Year)
07/27/2025
4. If Amendment, Date of Original Filed (Month/Day/Year)
6. Individual or Joint/Group Filing (Check Applicable Line)
X Form filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
Common Stock 07/27/2025 A 50,000(1) A $0 265,000 D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year) 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Explanation of Responses:
1. Includes 10,000 restricted stock units that vest on January 1, 2026, 20,000 restricted stock units that vest on January 1, 2027 and 20,000 restricted stock units that vest on January 1, 2028.
/s/ Shayna Webb Dray 07/31/2025
** Signature of Reporting Person Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

How many Ollie's (OLLI) RSUs vested for EVP Christopher Zender on July 29 2025?

A total of 758 restricted stock units vested and converted into common shares.

How many OLLI shares were surrendered for tax withholding?

Zender surrendered 338 shares at $137.89 to cover withholding taxes.

What is Christopher Zender’s remaining OLLI equity after the Form 4 filing?

He now directly owns 420 common shares and 2,274 unvested RSUs.

Did the OLLI COO buy or sell shares on the open market?

No. The transactions were automatic vesting and share withholding, not open-market sales.
Lifemd, Inc.

NASDAQ:LFMDP

LFMDP Rankings

LFMDP Latest News

LFMDP Latest SEC Filings

LFMDP Stock Data

1.40M
Health Information Services
Services-offices & Clinics of Doctors of Medicine
Link
United States
NEW YORK